Sponsor:
Children's Hospital of Philadelphia
Code:
NCT05932589
Conditions
Rett Syndrome
RTT
Rett Syndrome, Atypical
Eligibility Criteria
Sex: Female
Age: 1 - 18
Healthy Volunteers: Accepted
Interventions
EEG and Auditory and Visual Evoked Potentials (AEP and VEP)
Clinical assessment
Brief summary:
Conditions
Rett Syndrome
RTT
Rett Syndrome, Atypical
Study ID
NCT05932589
Start date
Oct 11, 2023
Status verified date
Oct, 2025
Completion date
Mar 31, 2029
Anticipated
Primary completion date
Mar 31, 2028
Anticipated
Eligibility Criteria
Sex: Female
Age: 1 - 18
Healthy Volunteers: Accepted
Enrollment
202 participants
Anticipated
Arms
RTT Females
Controls
Interventions
EEG and Auditory and Visual Evoked Potentials (AEP and VEP)
Clinical assessment
Primary outcome measure
Central contacts
Locations
Children's Hospital of Los Angeles
Recruiting
Los Angeles, California, United States, 90027
Principal Investigator:
Shefali Spurling Jeste, MD
Children's Hospital Colorado
Recruiting
Aurora, Colorado, United States, 80045
Principal Investigator:
Timothy Benke, MD, PhD
Boston Children's Hospital
Recruiting
Brookline, Massachusetts, United States, 02445
Principal Investigator:
April Levin, MD
Children's Hospital of Philadelphia
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Principal Investigator:
Eric Marsh, MD, PhD
Vanderbilt University Medical Center
Recruiting
Nashville, Tennessee, United States, 37232
Contacts
Principal Investigator:
Jeffrey Neul, MD, PhD
Texas Children's Hospital
Recruiting
Houston, Texas, United States, 77030
Principal Investigator:
Bernhard Suter, MD
Sponsor
Children's Hospital of Philadelphia
Last update posted
Oct 20, 2025
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Children's Hospital of Philadelphia on 2025-10-20.